Acute coronary syndromes - clopidogrel
Clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome
| Guidance type: Technology appraisal |
| Date issued: July 2004 |
We will consult on our review plans for this guidance in July 2007. |
| Reference: TA80 |
SummaryClopidogrel, together with a low dose of aspirin, should be used for people with non-ST-segment-elevation acute coronary syndrome who have a moderate to high risk of a major heart attack (myocardial infarction) or death. Whether a person is at moderate to high risk of a major heart attack can be judged from their symptoms and by one or both of the following test results.
Treatment with clopidogrel and low-dose aspirin should be continued for up to 12 months after the most recent attack. After this time, doctors should give the normal treatment, which includes a low dose of aspirin. |
| Top |
Implementing this guidanceAny further information NICE has produced to help the NHS implement this guideline locally is linked to below:
|
| Top |
